217 related articles for article (PubMed ID: 34341278)
1. CD3-positive plasmablastic lymphoma reported in two cases: A potential diagnostic caveat.
Wong YP; Masir N; Chew MX
Indian J Pathol Microbiol; 2021; 64(3):579-583. PubMed ID: 34341278
[TBL] [Abstract][Full Text] [Related]
2. CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall.
Pan Z; Chen M; Zhang Q; Wang E; Yin L; Xu Y; Huang Q; Yuan Y; Zhang X; Zheng G; Yuan J
Mod Pathol; 2018 May; 31(5):718-731. PubMed ID: 29327711
[TBL] [Abstract][Full Text] [Related]
3. Lymphoid neoplasms of the oral cavity with plasmablastic morphology-a case series and review of the literature.
Bhattacharyya S; Bains APS; Sykes DL; Iverson BR; Sibgatullah R; Kuklani RM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Dec; 128(6):651-659. PubMed ID: 31494113
[TBL] [Abstract][Full Text] [Related]
4. CD3-and CD20-negative extramedullary non-Hodgkin leukemia/lymphoma: a histopathological study of 118 cases.
Maeshima AM; Taniguchi H; Hattori D; Sasaki H; Hori Y; Makita S; Iwaki N; Fukuhara S; Munakata W; Suzuki T; Izutsu K
Hum Pathol; 2022 Jun; 124():14-23. PubMed ID: 35307403
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
[TBL] [Abstract][Full Text] [Related]
6. Plasmablastic lymphoma: a clinicopathologic correlation.
Folk GS; Abbondanzo SL; Childers EL; Foss RD
Ann Diagn Pathol; 2006 Feb; 10(1):8-12. PubMed ID: 16414538
[TBL] [Abstract][Full Text] [Related]
7. From the archives of MD Anderson Cancer Center: Plasmablastic lymphoma presenting as a kidney mass in an immunocompetent patient: Case report and literature review.
Gietzen R; Muthukumarana V; Bhargava P; Vozniuk D; Thakral B; Medeiros LJ; Lyapichev KA
Ann Diagn Pathol; 2023 Dec; 67():152186. PubMed ID: 37541853
[TBL] [Abstract][Full Text] [Related]
8. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.
Colomo L; Loong F; Rives S; Pittaluga S; Martínez A; López-Guillermo A; Ojanguren J; Romagosa V; Jaffe ES; Campo E
Am J Surg Pathol; 2004 Jun; 28(6):736-47. PubMed ID: 15166665
[TBL] [Abstract][Full Text] [Related]
9. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
Meer S; Perner Y; McAlpine ED; Willem P
Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
[TBL] [Abstract][Full Text] [Related]
10. Plasmablastic lymphoma: current knowledge and future directions.
Li JW; Peng HL; Zhou XY; Wang JJ
Front Immunol; 2024; 15():1354604. PubMed ID: 38415257
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features of B-Cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases.
Oliveira JL; Grogg KL; Macon WR; Dogan A; Feldman AL
Am J Surg Pathol; 2012 Sep; 36(9):1364-70. PubMed ID: 22895269
[TBL] [Abstract][Full Text] [Related]
12. Plasmablastic lymphoma of the oral cavity with breast recurrence: a case report.
Samoon Z; Idrees R; Masood N; Ansari TZ
BMC Res Notes; 2015 May; 8():180. PubMed ID: 25933603
[TBL] [Abstract][Full Text] [Related]
13. Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis.
Harmon CM; Smith LB
Arch Pathol Lab Med; 2016 Oct; 140(10):1074-8. PubMed ID: 27684979
[TBL] [Abstract][Full Text] [Related]
14. Plasmablastic Lymphoma Mimicking Acute Pancreatitis.
Inayat F; Virk HU; Cheema AR; Saif MW
Case Rep Oncol Med; 2016; 2016():9751736. PubMed ID: 27034868
[TBL] [Abstract][Full Text] [Related]
15. Oral plasmablastic lymphoma: A clinicopathological study of 113 cases.
Fonseca FP; Robinson L; van Heerden MB; van Heerden WFP
J Oral Pathol Med; 2021 Jul; 50(6):594-602. PubMed ID: 34091967
[TBL] [Abstract][Full Text] [Related]
16. Malignant ulcer: a great mimicker of gastric plasmablastic lymphoma.
Johan S; Khairuddin A; Zuki AM; Teng WW; Hayati F; Mra A; Azizan N
Clin J Gastroenterol; 2021 Aug; 14(4):1027-1030. PubMed ID: 33797037
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin expression in plasmablastic lymphoma - a possible diagnostic pitfall in the routine work-up of tumours.
Huettl KS; Staiger AM; Horn H; Frontzek F; Goodlad JR; Tapia G; Rosenwald A; Klapper W; Fend F; Climent F; Castellvi J; Tzankov A; Dirnhofer S; Baptista MJ; Navarro JT; Anagnostopoulos I; Hartmann W; Lenz G; Ott G
Histopathology; 2021 May; 78(6):831-837. PubMed ID: 33165992
[TBL] [Abstract][Full Text] [Related]
18. Plasmablastic lymphoma involving the penis: a previously unreported location of a case with aberrant CD3 expression.
Sun J; Medeiros LJ; Lin P; Lu G; Bueso-Ramos CE; You MJ
Pathology; 2011 Jan; 43(1):54-7. PubMed ID: 21240066
[TBL] [Abstract][Full Text] [Related]
19. Plasmablastic lymphoma: An update.
Bailly J; Jenkins N; Chetty D; Mohamed Z; Verburgh ER; Opie JJ
Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):54-63. PubMed ID: 36074710
[TBL] [Abstract][Full Text] [Related]
20. Plasmablastic lymphoma of bone marrow: Report of a rare case and immunohistochemistry based approach to the diagnosis.
Sharma P; Sreedharanunni S; Koshy A; Prakash G; Sachdeva MUS; Malhotra P
Indian J Pathol Microbiol; 2019; 62(1):107-110. PubMed ID: 30706870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]